Analytical Data
-
Gene name
TSI3
- Application
-
Alternative Names
Immune protein Tsi3; Anti-toxin protein Tsi3; tsi3; Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)
-
Species
Others
-
Source
E. coli
-
Tag
Strep;His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9HYC4
-
Expression Region
G21-Q145
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The TSI3 protein, a member of the TGF-beta (transforming growth factor-beta) superfamily, has garnered significant interest in recent years due to its potential roles in various biological processes, including cell proliferation, differentiation, and immune response regulation. Research has indicated that TSI3 is involved in developmental pathways and tissue homeostasis, making it a crucial factor in both normal physiology and pathophysiology, such as fibrosis and cancer. The recombinant expression of TSI3 allows for detailed studies of its functional properties, enabling researchers to explore its mechanisms of action and interactions with other signaling pathways. Additionally, TSI3's involvement in immune system modulation has implications for therapeutic strategies in autoimmune diseases and cancer immunotherapy. As scientists continue to decipher the specific roles and mechanisms of TSI3, the potential for its application in biomedicine becomes increasingly apparent, emphasizing the importance of generating high-quality recombinant protein for experimental validation and therapeutic development.
